184 research outputs found
Figure S1 - Supplemental material for Optimizing Discharge After Shorter Hospitalizations: Lessons Learned Through After-Hours Calls with Thoracic Surgical Patients
No full textSupplemental material, Figure S1, for Optimizing Discharge After Shorter Hospitalizations: Lessons Learned Through After-Hours Calls with Thoracic Surgical Patients by Alisa N. Blumenthaler, Nicolas Zhou, Kavita Parikh, Wayne L. Hofstetter, Reza J. Mehran, Ravi Rajaram, David C. Rice, Boris Sepesi, Stephen G. Swisher, Ara A. Vaporciyan, Garrett L. Walsh and Mara B. Antonoff in Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery</p
Supplementary Material 1 - Supplemental material for Optimizing Discharge After Shorter Hospitalizations: Lessons Learned Through After-Hours Calls with Thoracic Surgical Patients
No full textSupplemental material, Supplementary Material 1, for Optimizing Discharge After Shorter Hospitalizations: Lessons Learned Through After-Hours Calls with Thoracic Surgical Patients by Alisa N. Blumenthaler, Nicolas Zhou, Kavita Parikh, Wayne L. Hofstetter, Reza J. Mehran, Ravi Rajaram, David C. Rice, Boris Sepesi, Stephen G. Swisher, Ara A. Vaporciyan, Garrett L. Walsh and Mara B. Antonoff in Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery</p
Visual Abstract - Supplemental material for Optimizing Discharge After Shorter Hospitalizations: Lessons Learned Through After-Hours Calls with Thoracic Surgical Patients
No full textSupplemental material, Visual Abstract, for Optimizing Discharge After Shorter Hospitalizations: Lessons Learned Through After-Hours Calls with Thoracic Surgical Patients by Alisa N. Blumenthaler, Nicolas Zhou, Kavita Parikh, Wayne L. Hofstetter, Reza J. Mehran, Ravi Rajaram, David C. Rice, Boris Sepesi, Stephen G. Swisher, Ara A. Vaporciyan, Garrett L. Walsh and Mara B. Antonoff in Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery</p
Lung Cancer Surgery in the Era of Immunotherapy
No full textFilmed at the 2019 STS Annual Meeting in San Diego, California, Mara Antonoff of the University of Texas MD Anderson Cancer Center in Houston, USA, moderates a discussion on how immunotherapy is changing the landscape of surgical lung cancer care. Dr Antonoff is joined by Boris Sepesi of the University of Texas MD Anderson Cancer Center, Linda Martin of the University of Virginia in Charlottesville, USA, and Stephen Broderick of Johns Hopkins University in Baltimore, Maryland, USA. They review the indications for and efficacy of immunotherapy in lung cancer. Noting the many outstanding questions that remain, each panelist briefly highlights the research goals of trials in which they are involved, including the NEOSTAR trial (ClinicalTrials.gov, NCT03158129), a phase II trial through the Alliance Foundation, and the CheckMate 816 trial (ClinicalTrials.gov, NCT02998528). The group discusses how immunotherapy might change the population of patients undergoing surgery, both in late-stage and early-stage disease. Finally, the panelists emphasize the importance of multidisciplinary care, considering all available therapeutic options to provide the best care for each patient
The Influence of Body Mass Index on Overall Survival Following Surgical Resection of Non–Small Cell Lung Cancer
No full textAbstract
Prior work implicated an association between increased body mass index (BMI) and lower risk of mortality from lung cancer. The aim of our study was to comprehensively evaluate the influence of BMI on long-term overall survival in surgical patients with non-small cell lung cancer. This study investigated 1935 patients who underwent surgical resection for lung cancer at MD Anderson Cancer Center (from 2000 - 2014). Study variables included both patient and treatment related characteristics. Univariate and multivariate Cox regression analyses were performed to identify variables associated with overall survival. By univariate analysis, significant predictors of better survival were higher BMI, pathologic tumor stage (stage I versus stages II, III, or IV), type of surgery (lobectomy/pneumonectomy versus wedge resection/segmentectomy), younger age, female gender, and adenocarcinoma histology (versus squamous) (all p &lt; 0.05). Patients considered morbidly obese (BMI ≥ 35) had a trend towards better outcomes than those classified as obese (BMI ≥ 30 and &lt;35) (p = 0.05), overweight (BMI ≥25 and &lt;30) (p = 0.13), or healthy weight (BMI &lt; 25) (p = 0.37) (HR 0.727, 0.848, 0.926, and 1, respectively). By multivariate analysis, BMI remained an independent predictor of survival (p = 0.02). Propensity matching analysis showed significantly better overall survival (p = 0.008) in patients with BMI ≥ 30 as compared to BMI &lt; 25. For exploratory analysis of expressed mRNAs associated with obesity in lung cancer, the association between obesity-related species (LEP, LEPR, PCSK1, POMC, MC4R, BMIQ1, BMIQ2, BMIQ3, UCP2, BMIQ5, BMIQ6, INSIG2, FTO, TMEM18, GNPDA2, NEGR1, BDNF, KCTD15, SH2B1, MTCH2 and NPC1) and survival was explored using The Cancer Genome Atlas (TCGA). Kaplan Meier analyses demonstrated significantly improved overall survival in lung cancer patients with higher Uncoupling Protein 2 (UCP2) expression, as will be presented. In summary, this large, single center series, after controlling for disease stage and other variables found higher BMI was associated with improved overall survival following surgical resection of non-small cell lung cancer. Studies are underway to elucidate the underlying mechanisms responsible for this association between BMI and lung cancer survival.
Citation Format: Xi Liu, Boris Sepesi, Kathryn A. Gold, Arlene M. Correa, John V. Heymach, Ara A. Vaporciyan, Jason Roszik, Ethan Dmitrovsky. The influence of body mass index on overall survival following surgical resection of non-small cell lung cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 5734. doi:10.1158/1538-7445.AM2017-5734</jats:p
- …
